Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Neuro-Oncology AdvancesOpen Access

60 Investigating Setd2 Mutations in Neurodevelopment Using Cerebral Organoid Models

View Full Paper
Ask AI
Bookmark
Share

Authors

EYEmily YehLBLauren BlumePAPariya Azarafshar

Discussion

Loading...

Member takes

Overview

Observational analysis shows SETD2 mutations affect epigenetic regulation in neurodevelopment, suggesting implications for glioma progression.

Key Points

  • SETD2 mutations cause distinct epigenetic and transcriptional dysregulation, impacting early brain development in organoid models.
  • Preliminary results reveal that SETD2 LOF mutations are associated with poor prognosis in pediatric high-grade gliomas.
  • CRISPR-Cas9 was employed to introduce SETD2 mutations in human embryonic stem cells, generating mutants for detailed analysis.
  • Understanding the effects of SETD2 mutations may guide therapeutic developments for gliomas and neurodevelopmental disorders.

Cite This Study

Yeh et al. (2025) studied this question.

synapsesocial.com/papers/68c23965b210217d6477b744https://doi.org/10.1093/noajnl/vdaf166.055
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mutations of schizophrenia risk gene SETD1A dysregulate synaptic function in human neurons2025 · 7 citations
  2. 2Abstract P75: THE ROLE OF SETD2 IN THE MOLECULAR ONCOGENESIS OF GLIOMA THROUGH m6A RNA MODIFICATION2025
  3. 3SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation2025 · 3 citations
  4. 4SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation2025
  5. 5SETD2 deficiency in chronic myeloid leukemia (CML) contributes to tyrosine kinase inhibitor (TKI) resistance and disease acceleration by enhancing genetic instability and rewiring cellular metabolism and might be a novel biomarker of high risk disease since diagnosis2025